FORMULARY DECISION
Folic acid + 5-Fluorouracil + Irinotecan + Oxaliplatin : FOLFIRINOX
For use in palliative chemotherapy for inoperable pancreatic adenocarcinoma in good performance status patients.
Search Results
All Content Formulary Only Other ContentWe have found 23 results when searching "Folic acid"
FORMULARY DECISION
Folic acid + 5-Fluorouracil + Irinotecan + Oxaliplatin : FOLFIRINOX
As adjuvant treatment following potentially curative resection of pancreatic cancer.
FORMULARY DECISION
Folic acid + 5-Fluorouracil + Oxaliplatin : FOLFOX
Second-line combination chemotherapy regimen for patients with pancreatic cancer who have progressed after first–line gemcitabine-based chemotherapy and are of very good performance status.